As one of the most important symptoms used to assess the progression of ALS, the weight loss of mice injected with AAV9-RabGGTB-GFP+ was also significantly delayed (Figure 6D). The gene discussed is RABGGTB; the disease is amyotrophic lateral sclerosis.